Treatment of hepatitis C virus genotype 3 infection with direct-acting antiviral agents

por Zanaga, L.P., Miotto, N., Mendes, L.C., Stucchi, R.S.B., Vigani, A.G.
Publicado 2016

Recurrent hepatitis C treatment with direct acting antivirals – a real life study at a Brazilian liver transplant center

por Zanaga, L.P., Santos, A.G., Ataíde, E.C., Boin, I.F.S.F., Stucchi, R.S.B.
Publicado 2019

Transient elastography and APRI score: looking at false positives and false negatives. Diagnostic performance and association to fibrosis staging in chronic hepatitis C

por Mendes, L.C., Ferreira, P.A., Miotto, N., Zanaga, L., Gonçales, E., Lazarini, M.S., Gonçales, F.L., Stucchi, R.S.B., Vigani, A.G.
Publicado 2016

Survival benefits of interferon-based therapy in patients with recurrent hepatitis C after orthotopic liver transplantation

por Zanaga, L.P., Vigani, A.G., Angerami, R.N., Giorgetti, A., Escanhoela, C.A.F., Ataíde, E.C., Boin, I.F.S.F., Stucchi, R.S.B.
Publicado 2017

Predictors of early treatment discontinuation and severe anemia in a Brazilian cohort of hepatitis C patients treated with first-generation protease inhibitors

por Miotto, N., Mendes, L.C., Zanaga, L.P., Goncales, E.S.L., Lazarini, M.S.K., Pedro, M.N., Goncales, F.L., Stucchi, R.S.B., Vigani, A.G.
Publicado 2016